Whether you want to collect passive income or record market-beating returns, investing in dividend-paying companies can help you achieve both goals. And with the equities market currently experiencing a downturn, many dividend stocks look reasonably valued. Income-seeking investors have plenty of options from which to choose.

Let's consider two of them: Biotech giant Gilead Sciences (NASDAQ: GILD) and generic drug specialist Viatris (NASDAQ: VTRS). Here's why both healthcare companies are worth purchasing for dividend-seeking investors. 

Continue reading

Source Fool.com